Tracy Kinjerski, M.S.
Contracting, Pricing, Proposals, Revenue Generation, Business Operations & Processes
714-***-****, **************@*****.***, Maryland SUMMARY
Dynamic executive leader with over 20 years of experience leading teams, strategic pricing, contracts, proposals, business development, driving operational efficiency across public, private, non-profit CDMO’s, biotech and biopharmaceutical industries. Proven track record of increasing revenue growth, achieving a remarkable 146% increase within 12 months. Expertise in negotiating RFPs, proposal generation and contract negotiation as well as creating impactful business strategies that drive profitability. Committed to leveraging specialized skills to optimize strategies and contribute to organizational success.
WORK EXPERIENCE
Jan 2020 – Present President & Founder, Atrium Transformations, Alira Health, TK Biotech Industry Consulting Firm
• Consulted as a strategic partner for biopharmaceutical and biotech companies, pioneering CMC outsourcing partnerships and business transformations.
• Facilitated business model transformations to drive change and enhance revenues, operations, development, and marketing effectiveness.
• Collaborated with business clients throughout the entire RFP (Request for Proposal) process, overseeing supplier evaluation and selection.
• Generated and negotiated RFPs, proposals, and scopes of work for CMC outsourcing initiatives.
• Formulated and evaluated business plans, devising business and marketing strategies and tactics for successful execution.
• Pricing, proposals and contract negotiations on behalf of partners. Aug 2022 – Apr 2024 Vice President, General Manager, Comprehensive Cell Solutions Cell and Gene Therapy CDMO
• Orchestrated corporate leadership and strategic initiatives to establish and launch a CGT (Cell and Gene Therapy) CDMO.
• Responsible for leading all operations teams across the CDMO.
• Generated and negotiated contracts: suppliers, clients, acquisitions.
• Responsible for and led proposal team, scopes of work and pricing.
• In partnership with my team completed facility designs, diligence, acquisition, and expansion.
• Maximized profits through strategic pricing models and comprehensive cost management tactics.
• Implemented aggressive sales growth strategies to significantly increase revenue and expand market share.
Dec 2021 – Aug 2022 Vice President, Business Development & Marketing, Landmark Bio Cell and Gene Therapy CDMO
• Participated in corporate strategic planning leading up to the facility build phase.
• Spearheaded the planning, branding, and successful launch of Landmark as an innovative CGT CDMO.
• Executed contracts with pioneering developers for critical process development activities.
• Identified clients, generated proposals, pricing guidelines and negotiation, contracts. May 2017 – Jan 2020 Vice President, Business Operations, Avid Bioservices Mammalian and Gene Therapy CDMO
• Directed a comprehensive business model transformation, successfully establishing Avid Bioservices as a leader in the industry.
• Accelerated revenue from $24M to $67M within 12 months, achieving a remarkable 146% revenue growth. Feb 2016 – May 2017 Global Business Development Senior Director, CMC Biologics Global Biologics CDMO
• Oversaw east coast business development, cultivating proposals and client engagement to sustain strong relationships, contracts, and client engagement activities, scopes of work, CRM establishment and training. May 2011 – Jan 2016 Director Commercial Development, Fujifilm Diosynth Biotechnologies Global Biologics CDMO
• Managed biopharma, biotech, and government client acquisition efforts, driving impactful business development initiatives.
Jan 2006 – Jan 2010 Commercial Development Manager, Avecia Biologics (FujiFilm Diosynth) Global Microbial CDMO
• Directed commercial development efforts for east coast pharma, biotech, and government clients, covering projects from discovery to late phase. Included pricing, proposals, contracting as well as client engagement and coordination of internal and external visits with appropriate teams. Feb 2010 – Apr 2011 Director, Business Development, Althea Technologies (Ajinomoto) Drug product and mammalian development and manufacturing CDMO
• Championed business development initiatives across the east coast, focusing on client retention and repeat business opportunities.
EDUCATION
May 1993 – Dec 1996 Hood College
M.S., Molecular Biology Biomedical Sciences
Aug 1985 – May 1989 Hood College
B.A., Biology, Virology
Maryland, USA
Maryland, USA
SKILLS
CDMO Creation and Launch
Business Model Transformation
Corporate Forecasting
Revenue Growth Strategies
Contract Negotiation
Project Management
P&L Management
Market Assessments
Custom CRM Implementation
Strategic Planning Team Building
Coaching and Mentoring
Client Relationship Management
Communication Skills
AFFILIATIONS
• CELLS, Volunteer teaching, business operations, planning, fund raising
• American Cancer Society, Board Member
• FITCI, Frederick Innovative Technology Center, Strategic Growth & Advisory Board Member
• DCAT (Drug, Chemical & Associated Technologies, non-profit), Education Committee
• Executive Women in BIO Chair & Boardroom ready program ISPE Organization